These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: Tanner R; Satti I; Harris SA; O'Shea MK; Cizmeci D; O'Connor D; Chomka A; Matsumiya M; Wittenberg R; Minassian AM; Meyer J; Fletcher HA; McShane H Front Immunol; 2019; 10():2983. PubMed ID: 31998295 [TBL] [Abstract][Full Text] [Related]
3. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
4. Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains. Painter H; Willcocks S; Zelmer A; Reljic R; Tanner R; Fletcher H Tuberculosis (Edinb); 2024 May; 146():102494. PubMed ID: 38367368 [TBL] [Abstract][Full Text] [Related]
5. RUTI Vaccination Enhances Inhibition of Mycobacterial Growth Prabowo SA; Painter H; Zelmer A; Smith SG; Seifert K; Amat M; Cardona PJ; Fletcher HA Front Immunol; 2019; 10():894. PubMed ID: 31114572 [TBL] [Abstract][Full Text] [Related]
6. Development and application of the direct mycobacterial growth inhibition assay: a systematic review. Painter H; Harriss E; Fletcher HA; McShane H; Tanner R Front Immunol; 2024; 15():1355983. PubMed ID: 38380319 [TBL] [Abstract][Full Text] [Related]
7. Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells. Tanner R; Smith SG; van Meijgaarden KE; Giannoni F; Wilkie M; Gabriele L; Palma C; Dockrell HM; Ottenhoff THM; McShane H J Immunol Methods; 2019 Jun; 469():1-10. PubMed ID: 30710562 [TBL] [Abstract][Full Text] [Related]
8. In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy. Tanner R; O'Shea MK; Fletcher HA; McShane H Vaccine; 2016 Sep; 34(39):4656-4665. PubMed ID: 27527814 [TBL] [Abstract][Full Text] [Related]
9. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis. Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524 [TBL] [Abstract][Full Text] [Related]
11. Jia Q; Masleša-Galić S; Nava S; Horwitz MA mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945 [TBL] [Abstract][Full Text] [Related]
12. A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity. Vergara EJ; Tran AC; Paul MJ; Harrison T; Cooper A; Reljic R NPJ Vaccines; 2024 Jul; 9(1):123. PubMed ID: 38956057 [TBL] [Abstract][Full Text] [Related]
13. A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates. Tanner R; White AD; Boot C; Sombroek CC; O'Shea MK; Wright D; Hoogkamer E; Bitencourt J; Harris SA; Sarfas C; Wittenberg R; Satti I; Fletcher HA; Verreck FAW; Sharpe SA; McShane H NPJ Vaccines; 2021 Jan; 6(1):3. PubMed ID: 33397986 [TBL] [Abstract][Full Text] [Related]
14. Lee H; Kim J; Kang YA; Kim DR; Sim B; Zelmer A; Fletcher HA; Dockrell HM; Smith SG; Cho SN Front Immunol; 2019; 10():896. PubMed ID: 31105706 [No Abstract] [Full Text] [Related]
15. Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb). Marsay L; Matsumiya M; Tanner R; Poyntz H; Griffiths KL; Stylianou E; Marsh PD; Williams A; Sharpe S; Fletcher H; McShane H Tuberculosis (Edinb); 2013 Sep; 93(5):551-7. PubMed ID: 23726784 [TBL] [Abstract][Full Text] [Related]
16. A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development. Pepponi I; Khatri B; Tanner R; Villarreal-Ramos B; Vordermeier M; McShane H Tuberculosis (Edinb); 2017 Sep; 106():118-122. PubMed ID: 28802398 [TBL] [Abstract][Full Text] [Related]
17. Replacing, reducing and refining the use of animals in tuberculosis vaccine research. Tanner R; McShane H ALTEX; 2017; 34(1):157-166. PubMed ID: 27667476 [TBL] [Abstract][Full Text] [Related]
18. A simplified mycobacterial growth inhibition assay (MGIA) using direct infection of mouse splenocytes and the MGIT system. Yang AL; Schmidt TE; Stibitz S; Derrick SC; Morris SL; Parra M J Microbiol Methods; 2016 Dec; 131():7-9. PubMed ID: 27650198 [TBL] [Abstract][Full Text] [Related]
19. Impact of individual-level factors on Ex vivo mycobacterial growth inhibition: Associations of immune cell phenotype, cytomegalovirus-specific response and sex with immunity following BCG vaccination in humans. Prabowo SA; Smith SG; Seifert K; Fletcher HA Tuberculosis (Edinb); 2019 Dec; 119():101876. PubMed ID: 31698310 [TBL] [Abstract][Full Text] [Related]
20. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates. Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]